Agilon Health, Inc. (AGL) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
AGL EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
AGL Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | -3.2% | -7.1% | -6.8% |
| 2024 | 0.1% | -4.8% | -4.3% |
| 2023 | 1.6% | -5.4% | -6.1% |
| 2022 | 4.7% | -4.4% | -4.5% |
| 2021 | 4.3% | -24.5% | -26.7% |
Download Data
Export AGL earnings history in CSV or JSON format
Free sign-in required to download data
Agilon Health, Inc. (AGL) Earnings Overview
As of May 8, 2026, Agilon Health, Inc. (AGL) reported trailing twelve-month net income of -$373M, reflecting -55.6% year-over-year growth. The company earned $-22.42 per diluted share over the past four quarters, with a net profit margin of -6.8%.
Looking at the long-term picture, AGL's historical earnings data spans multiple years. The company achieved its highest annual net income of -$60M in fiscal 2020.
Agilon Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CNC (-$6.44B net income, -3.4% margin), HUM ($1.13B net income, 0.9% margin), CVS ($2.93B net income, 0.4% margin), AGL has room to improve margins relative to the peer group. Compare AGL vs CNC →
AGL Earnings vs Peers
Earnings metrics vs comparable public companies
AGL Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$405M | -55.8% | -$421M | $-24.50 | -6.8% | -7.1% |
| 2024 | -$260M | +0.9% | -$292M | $-15.75 | -4.3% | -4.8% |
| 2023 | -$263M | -146.4% | -$232M | $-16.00 | -6.1% | -5.4% |
| 2022 | -$107M | +73.8% | -$105M | $-6.50 | -4.5% | -4.4% |
| 2021 | -$406M | -576.9% | -$372M | $-27.25 | -26.7% | -24.5% |
| 2020 | -$60M | +78.7% | -$57M | $-4.00 | -4.9% | -4.7% |
| 2019 | -$283M | - | -$107M | $-18.50 | -35.6% | -13.4% |
See AGL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AGL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AGL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAGL — Frequently Asked Questions
Quick answers to the most common questions about buying AGL stock.
Is AGL growing earnings?
AGL EPS fell to $-22.42, with earnings declining -55.6%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-373M.
What are AGL's profit margins?
Agilon Health, Inc. net margin is -6.8%, with operating margin at -7.1%. Below-average margins reflect competitive or cost pressures.
How consistent are AGL's earnings?
AGL earnings data spans 2019-2025. The declining earnings trend is -55.6% YoY. Historical data enables comparison across business cycles.